Question of the Day September 21, 2014 Isn't IACP between a rock and a hard place on the office use question?

 They didn't like the answer the FDA provided. If they go to court on the issue and win, Congress or states could turn around and pass very clear legislation overruling the case law and  prohibiting office use unless compounds come from an outsourcing facility and they could make it apply to veterinary compounds.  If they go to court and lose, they will have no arguments left.  I don't see the majority of Congress amending the DQSA because it would make the outsourcing provisions meaningless.  If Congress is going to amend it will be to include veterinary compounds in the DQSA or to give the FDA even more authority in light of more and more bad inspections, more and more information coming out showing the dangers of compounded medications and the lack of potency, fraud and abuse etc. in the industry.  It will be interesting to see what IACP's next move is.  I wonder if they have ever thought their next move should be compliance with the laws and clearning up the industry gone bad- rather than continuing down the same path.  That might go along way toward fixing the bad reputation and image of compounding pharmacists.  I don't see it happening, however, because of greed and the amount of huge profits compounding pharmacists stand to lose if they actually follow the law and do what is right.